# Hill House Capital's Biotech Investments: 32 Startups in Its Portfolio (2026) > The 32 Biotech startups Hill House Capital has backed, by stage: $6.2B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/hill-house-capital-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Series B 11 - [*G* Grail](https://millionrounds.com/company/grail) - [Gossamer Bio](https://millionrounds.com/company/gossamer-bio) - [*C* CStone](https://millionrounds.com/company/cstone) - [*VB* Viela Bio](https://millionrounds.com/company/viela-bio) - [Haihe Biopharma](https://millionrounds.com/company/haihe-biopharma) - [Neon Therapeutics](https://millionrounds.com/company/neon-therapeutics) - [*T* TCR2](https://millionrounds.com/company/tcr2) - [Bluepha](https://millionrounds.com/company/bluepha) - [Starna Therapeutics](https://millionrounds.com/company/starna-therapeutics) - [NextCure](https://millionrounds.com/company/nextcure) - [*TO* Targeting One](https://millionrounds.com/company/targeting-one) ## Series C and later 10 - [Arcus Biosciences](https://millionrounds.com/company/arcus-biosciences) - [Nature's Fynd](https://millionrounds.com/company/nature-s-fynd) - [Abogen Biosciences](https://millionrounds.com/company/abogen-biosciences) - [Antengene](https://millionrounds.com/company/antengene) - [*I* Innovent](https://millionrounds.com/company/innovent) - [Hookipa](https://millionrounds.com/company/hookipa) - [GRIT Biotechnology](https://millionrounds.com/company/grit-biotechnology) - [Antiva Biosciences](https://millionrounds.com/company/antiva-biosciences) - [WeMed](https://millionrounds.com/company/wemed) - [Qitan Technology](https://millionrounds.com/company/qitan-technology) ## Stage not reported 6 - [ArriVent](https://millionrounds.com/company/arrivent) - [Tenpoint Therapeutics](https://millionrounds.com/company/tenpoint-therapeutics) - [Arvinas](https://millionrounds.com/company/arvinas) - [*I* Innocare](https://millionrounds.com/company/innocare) - [Hookipa Pharma](https://millionrounds.com/company/hookipa-pharma) - [Everest Medicines](https://millionrounds.com/company/everest-medicines) ## Series A 5 - [Third Arc Bio](https://millionrounds.com/company/third-arc-bio) - [*E* Elpiscience](https://millionrounds.com/company/elpiscience) - [*DK* Deyun Kangrui](https://millionrounds.com/company/deyun-kangrui) - [UniXell Biotechnology](https://millionrounds.com/company/unixell-biotechnology) - [*HT* Hopson Technology](https://millionrounds.com/company/hopson-technology) ## Segment by segment ### Series B 11 startups · $3.7B raised - [*G* **Grail**](https://millionrounds.com/company/grail) United States $1.6B - [**Gossamer Bio**](https://millionrounds.com/company/gossamer-bio) Gossamer Bio is a biopharmaceutical company focused on the discovery and development of novel and differentiated therapeutic products. United States $567M - [*C* **CStone**](https://millionrounds.com/company/cstone) China $410M - [*VB* **Viela Bio**](https://millionrounds.com/company/viela-bio) Viela Bio is a clinical-stage biotechnology company pioneering and advancing treatments for severe inflammation and autoimmune diseases. United States $325M - [**Haihe Biopharma**](https://millionrounds.com/company/haihe-biopharma) Haihe Biopharma is a biopharmaceutical company that develops cancer anti-tumour drugs. China $317M - [**Neon Therapeutics**](https://millionrounds.com/company/neon-therapeutics) NEON Therapeutics is focused on unlocking the full potential of the immune system to recognize and attack cancer. United States $161M - [*T* **TCR2**](https://millionrounds.com/company/tcr2) United States $125M - [**Bluepha**](https://millionrounds.com/company/bluepha) Bluepha is a leading synthetic biology company in China, founded in 2016 by Dr. China $59M ### Series C and later 10 startups · $1.8B raised - [**Arcus Biosciences**](https://millionrounds.com/company/arcus-biosciences) Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer. United States $427M - [**Nature's Fynd**](https://millionrounds.com/company/nature-s-fynd) Nature's Fynd is a Chicago-based food-tech company that specializes in creating animal-free meat and dairy alternatives. United States $350M - [**Abogen Biosciences**](https://millionrounds.com/company/abogen-biosciences) Abogen Biosciences is a clinical-stage biotechnology company focused on RNA-based medicines, particularly in mRNA science and technology. China $300M - [**Antengene**](https://millionrounds.com/company/antengene) Antengene is a developer of biotechnology and bio-pharmaceuticals intended to provide medicine treatment for tumor. China $217M - [*I* **Innovent**](https://millionrounds.com/company/innovent) Hong Kong SAR China $150M - [**Hookipa**](https://millionrounds.com/company/hookipa) Hookipa GmbH – Private Equity, Finanzierungen, Start-Up Coaching und Vermittlung von Kontakten & Personal. Austria $97M - [**GRIT Biotechnology**](https://millionrounds.com/company/grit-biotechnology) Grit Biotechnology, also known as Grit Bio, is a clinical-stage biopharmaceutical company based in Shanghai, China. China $84M - [**Antiva Biosciences**](https://millionrounds.com/company/antiva-biosciences) Antiva Biosciences is a biopharmaceutical company developing therapeutics for the treatment of diseases caused by HPV infection. United States $75M ### Stage not reported 6 startups · $662M raised - [**ArriVent**](https://millionrounds.com/company/arrivent) ArriVent develops pharmaceutical products to cure presently untreatable cancer. United States $325M - [**Tenpoint Therapeutics**](https://millionrounds.com/company/tenpoint-therapeutics) Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics. United Kingdom $150M - [**Arvinas**](https://millionrounds.com/company/arvinas) Arvinas is a clinical-stage biotechnology company leading the way in targeted protein degradation therapeutics. United States $111M - [*I* **Innocare**](https://millionrounds.com/company/innocare) InnoCare is a Chinese biopharmaceutical company that develops treatment for cancer and autoimmune diseases. China $55M - [**Hookipa Pharma**](https://millionrounds.com/company/hookipa-pharma) Hookipa is a clinical stage biotech company developing best-in-class active immunization therapies for infectious diseases and oncology. United States $14M - [**Everest Medicines**](https://millionrounds.com/company/everest-medicines) Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients. United States $6.8M ### Series A 5 startups · $112M raised - [**Third Arc Bio**](https://millionrounds.com/company/third-arc-bio) Third Arc Bio is a clinical-stage biotechnology company based in Philadelphia, Pennsylvania, founded in 2022. United States $52M - [*E* **Elpiscience**](https://millionrounds.com/company/elpiscience) China $35M - [*DK* **Deyun Kangrui**](https://millionrounds.com/company/deyun-kangrui) Deyun Kangrui is a bio-medical high-tech enterprise that integrates R&D and the production of full-chain single-cell multi-omics technology. - $13M - [**UniXell Biotechnology**](https://millionrounds.com/company/unixell-biotechnology) UniXell Biotechnology is a new-generation cell therapy drug developer, focuses on the development of a new generation of cell therapy drugs. China $7.2M - [*HT* **Hopson Technology**](https://millionrounds.com/company/hopson-technology) Hopson Technology is a natural product synthesis technology developer. China $4.1M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Hill House Capital as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Sector portfolio **Hill House Capital's AI portfolio** 15 startups · $7.7B](https://millionrounds.com/portfolio-maps/hill-house-capital-ai-portfolio)[Portfolio map **Hill House Capital portfolio map** 107 startups · $36B](https://millionrounds.com/portfolio-maps/hill-house-capital-portfolio-map)[Co-investors **Who invests with Hill House Capital** 85 co-investors](https://millionrounds.com/portfolio-maps/hill-house-capital-co-investors)[Investments abroad **Hill House Capital's investments in China** 59 startups · $14B](https://millionrounds.com/portfolio-maps/hill-house-capital-investments-china)[Investments abroad **Hill House Capital's investments in the United States** 18 startups · $5.1B](https://millionrounds.com/portfolio-maps/hill-house-capital-investments-united-states)[Sector portfolio **Y Combinator's AI portfolio** 1,143 startups · $44B](https://millionrounds.com/portfolio-maps/y-combinator-ai-portfolio) ## Raising from investors like Hill House Capital? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)